Advances in the surgical treatment of hilar cholangiocarcinoma

References

• Miyakawa S, Ishihara S, Horiguchi A, et al. Biliary tract cancer treatment: 5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan. J Hepatobiliary Pancreat Surg 2009;16(1):1-7
   PubMedGoogle Scholar
• Ramia JM. Hilar cholangiocarcinoma. World J Gastrointest Oncol 2013;5(7):113-14
   PubMed Web of Science ®Google Scholar
• Soares KC, Kamel I, Cosgrove DP, et al. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr 2014;3(1):18-34
   PubMedGoogle Scholar
• Liu CL, Fan ST, Lo CM, et al. Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinoma. Br J Surg 2006;93(12):1488-94
   PubMed Web of Science ®Google Scholar
• Nagino M, Ebata T, Yokoyama Y, et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg 2013;258(1):129-40
   PubMed Web of Science ®Google Scholar
• Zhimin G, Noor H, Jian-Bo Z, et al. Advances in diagnosis and treatment of hilar cholangiocarcinoma – a review. Med Sci Monit 2013;19:648-56
   PubMed Web of Science ®Google Scholar
• Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992;215(1):31-8
   PubMed Web of Science ®Google Scholar
• Kawakami H, Kuwatani M, Etoh K, et al. Endoscopic retrograde cholangiography versus peroral cholangioscopy to evaluate intraepithelial tumor spread in biliary cancer. Endoscopy 2009;41(11):959-64
   PubMed Web of Science ®Google Scholar
• Sasaki Y, Okabe Y, Ishida Y, et al. Evaluation of Endoscopic transpapillary brushing cytology for the diagnosis of bile duct cancer based on the histopathologic findings. Dig Dis Sci 2014;59(9):2314-19
   PubMed Web of Science ®Google Scholar
• Sakamoto E, Nimura Y, Hayakawa N, et al. The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann Surg 1998;227(3):405-11
   PubMed Web of Science ®Google Scholar
• Nakanishi Y, Kondo S, Hirano S, et al. Recurrence of mucosal carcinoma of the bile duct, with superficial flat spread, 12 years after operation. J Hepatobiliary Pancreat Surg 2006;13(4):355-8
   PubMedGoogle Scholar
• Sasaki T, Kondo S, Ambo Y, et al. Local recurrence at hepaticojejunostomy 9 years after resection of bile duct cancer with superficial flat spread. J Hepatobiliary Pancreat Surg 2006;13(5):458-62
   PubMedGoogle Scholar
• Hirano S, Kondo S, Tanaka E, et al. Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality. J Hepatobiliary Pancreat Sci 2010;17(4):455-62
   PubMed Web of Science ®Google Scholar
• Nakanishi Y, Zen Y, Kawakami H, et al. Extrahepatic bile duct carcinoma with extensive intraepithelial spread: a clinicopathological study of 21 cases. Mod Pathol 2008;21(7):807-16
   PubMed Web of Science ®Google Scholar
• Igami T, Nagino M, Oda K, et al. Clinicopathologic study of cholangiocarcinoma with superficial spread. Ann Surg 2009;249(2):296-302
   PubMed Web of Science ®Google Scholar
• Sasaki R, Takeda Y, Funato O, et al. Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma. World J Surg 2007;31(9):1788-96
   PubMed Web of Science ®Google Scholar
• Ojima H, Kanai Y, Iwasaki M, et al. Intraductal carcinoma component as a favorable prognostic factor in biliary tract carcinoma. Cancer Sci 2009;100(1):62-70
   PubMed Web of Science ®Google Scholar
• Nimura Y, Kamiya J, Kondo S, et al. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg 2000;7(2):155-62
   PubMedGoogle Scholar
• Kondo S, Hirano S, Ambo Y, et al. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg 2004;240(1):95-101
   PubMed Web of Science ®Google Scholar
• Senda Y, Nishio H, Oda K, et al. Value of multidetector row CT in the assessment of longitudinal extension of cholangiocarcinoma: correlation between MDCT and microscopic findings. World J Surg 2009;33(7):1459-67
   PubMed Web of Science ®Google Scholar
• Schwarz RE, Smith DD. Lymph node dissection impact on staging and survival of extrahepatic cholangiocarcinomas, based on U.S. population data. J Gastrointest Surg 2007;11(2):158-65
   PubMed Web of Science ®Google Scholar
• Aoba T, Ebata T, Yokoyama Y, et al. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes. Ann Surg 2013;257(4):718-25
   PubMed Web of Science ®Google Scholar
• Noji T, Kondo S, Hirano S, et al. Computed tomography evaluation of regional lymph node metastases in patients with biliary cancer. Br J Surg 2008;95(1):92-6
   PubMed Web of Science ®Google Scholar
• Yonemori A, Kondo S, Matsuno Y, et al. Prognostic impact of para-aortic lymph node micrometastasis in patients with regional node-positive biliary cancer. Br J Surg 2009;96(5):509-16
   PubMed Web of Science ®Google Scholar
• Yonemori A, Kondo S, Matsuno Y, et al. Prognostic impact of regional lymph node micrometastasis in patients with node-negative biliary cancer. Ann Surg 2010;252(1):99-106
   PubMed Web of Science ®Google Scholar
• Yonemori A, Kondo S, Matsuno Y, et al. Para-aortic lymph node micrometastasis in patients with node-negative biliary cancer. Dig Surg 2010;28(4):315-21
   Web of Science ®Google Scholar
• Pang JC, Minter RM, Kwon RS, et al. The role of cytology in the preoperative assessment and management of patients with pancreaticobiliary tract neoplasms. J Gastrointest Surg 2013;17(3):501-10
   PubMed Web of Science ®Google Scholar
• Ramírez-Merino N, Aix SP, Cortés-Funes H. Chemotherapy for cholangiocarcinoma: an update. World J Gastrointest Oncol 2013;5(7):171-6
   PubMed Web of Science ®Google Scholar
• Nimura Y. Preoperative biliary drainage before resection for cholangiocarcinoma (Pro). HPB (Oxford) 2008;10(2):130-3
   PubMed Web of Science ®Google Scholar
• Kawakami H, Kondo S, Kuwatani M, et al. Preoperative biliary drainage for hilar cholangiocarcinoma: which stent should be selected? J Hepatobiliary Pancreat Sci 2011;18(5):630-5
   PubMed Web of Science ®Google Scholar
• Kawakami H, Kuwatani M, Onodera M, et al. Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma. J Gastroenterol 2011;46(2):242-8
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Nagino M, Nishio H, et al. Percutaneous transhepatic biliary drainage catheter tract recurrence in cholangiocarcinoma. Br J Surg 2010;97(12):1860-6
   PubMed Web of Science ®Google Scholar
• Hirano S, Tanaka E, Tsuchikawa T, et al. Oncological benefit of preoperative endoscopic biliary drainage in patients with hilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2014;21(8):533-40
   PubMed Web of Science ®Google Scholar
• Kawashima H, Itoh A, Ohno E, et al. Preoperative endoscopic nasobiliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma: a retrospective study of efficacy and risk factors related to complications. Ann Surg 2013;257(1):121-7
   PubMed Web of Science ®Google Scholar
• Nagino M, Kamiya J, Nishio H, et al. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg 2006;243(3):364-72
   PubMed Web of Science ®Google Scholar
• Abulkhir A, Limongelli P, Healey AJ, et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 2008;247(1):49-57
   PubMed Web of Science ®Google Scholar
• Ebata T, Yokoyama Y, Igami T, et al. Portal vein embolization before extended hepatectomy for biliary cancer: current technique and review of 494 consecutive embolizations. Dig Surg 2012;29(1):23-9
   PubMed Web of Science ®Google Scholar
• Sakuhara Y, Abo D, Hasegawa Y, et al. Preoperative percutaneous transhepatic portal vein embolization with ethanol injection. Am J Roentgenol 2012;198(4):914-22
   PubMed Web of Science ®Google Scholar
• Kinoshita H, Sakai K, Hirohashi K, et al. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 1986;10(5):803-8
   PubMed Web of Science ®Google Scholar
• Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990;107(5):521-7
   PubMed Web of Science ®Google Scholar
• Noji T, Tsuchikawa T, Okamura K, et al. Surgical outcome of hilar plate resection: extended hilar bile duct resection without hepatectomy. J Gastrointest Surg 2014;18(6):1131-7
   PubMed Web of Science ®Google Scholar
• Kawarada Y, Isaji S, Taoka H, et al. S4a + S5 with caudate lobe (S1) resection using the Taj Mahal liver parenchymal resection for carcinoma of the biliary tract. J Gastrointest Surg 1999;3(4):369-73
   PubMed Web of Science ®Google Scholar
• Mihara K, Sugiura T, Okamura Y, et al. A predictive factor of insufficient liver regeneration after preoperative portal vein embolization. Eur Surg Res 2013;51(3-4):118-28
   PubMed Web of Science ®Google Scholar
• Nanashima A, Abo T, Tobinaga S, et al. Prediction of indocyanine green retention rate at 15 minutes by correlated liver function parameters before hepatectomy. J Surg Res 2011;169(2):e119-25
   PubMed Web of Science ®Google Scholar
• Nanashima A, Tobinaga S, Abo T, et al. Reducing the incidence of post-hepatectomy hepatic complications by preoperatively applying parameters predictive of liver function. J Hepatobiliary Pancreat Sci 2010;17(6):871-8
   PubMed Web of Science ®Google Scholar
• Stockmann M, Malinowski M, Lock JF, et al. Factors influencing the indocyanine green (ICG) test: additional impact of acute cholestasis. Hepatogastroenterology 2009;56(91-92):734-8
   PubMedGoogle Scholar
• Fan ST. Liver functional reserve estimation: state of the art and relevance for local treatments: the Eastern perspective. J Hepatobiliary Pancreat Sci 2010;17(4):380-4
   PubMed Web of Science ®Google Scholar
• Kawarada Y, Higashiguchi T, Yokoi H, et al. Preoperative biliary drainage in obstructive jaundice. Hepatogastroenterology 1995;42(4):300-7
   PubMedGoogle Scholar
• Hirano S, Tanaka E, Shichinohe T, et al. Treatment strategy for hilar cholangiocarcinoma, with special reference to the limits of ductal resection in right-sided hepatectomies. J Hepatobiliary Pancreat Surg 2007;14(5):429-33
   PubMedGoogle Scholar
• Tsuzuki T, Ogata Y, Iida S, et al. Surgical anatomy of the hepatic hilum with special reference to the caudate lobe. Arch Surg 1983;118(10):1147-51
   PubMedGoogle Scholar
• Ebata T, Yokoyama Y, Igami T, et al. Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients. Ann Surg 2012;256(2):297-305
   PubMed Web of Science ®Google Scholar
• Matsumoto N, Ebata T, Yokoyama Y, et al. Role of anatomical right hepatic trisectionectomy for perihilar cholangiocarcinoma. Br J Surg 2014;101(3):261-8
   PubMed Web of Science ®Google Scholar
• Ebata T, Yokoyama Y, Igami T, et al. Review of hepatopancreatoduodenectomy for biliary cancer: an extended radical approach of Japanese origin. J Hepatobiliary Pancreat Sci 2014;21(8):550-5
   PubMed Web of Science ®Google Scholar
• Nagino M, Nimura Y, Nishio H, et al. Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases. Ann Surg 2010;252(1):115-23
   PubMed Web of Science ®Google Scholar
• Miyazaki M, Kimura F, Shimizu H, et al. Recent advance in the treatment of hilar cholangiocarcinoma: hepatectomy with vascular resection. J Hepatobiliary Pancreat Surg 2007;14(5):463-8
   PubMedGoogle Scholar
• Hirano S, Kondo S, Tanaka E, et al. No-touch resection of hilar malignancies with right hepatectomy and routine portal reconstruction. J Hepatobiliary Pancreat Surg 2009;16(4):502-7
   PubMedGoogle Scholar
• Hirano S, Kondo S, Tanaka E, et al. Safety of combined resection of the middle hepatic artery in right hemihepatectomy for hilar biliary malignancy. J Hepatobiliary Pancreat Surg 2009;16(6):796-801
   PubMedGoogle Scholar
• Murakami Y, Uemura K, Sudo T, et al. Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma. J Gastrointest Surg 2009;13(8):1470-9
   PubMed Web of Science ®Google Scholar
• Okusaka T, Nakachi K, Fukutomi A, et al. Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br J Cancer 2010;103(4):469-74
   PubMed Web of Science ®Google Scholar
• Gerhards MF, van Gulik TM, González González D, et al. Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma. World J Surg 2003;27(2):173-9
   PubMed Web of Science ®Google Scholar
• Ebata T, Kosuge T, Hirano S. Proposal to modify the International Union Against Cancer staging system for perihilar cholangiocarcinomas. Br J Surg 2014;101(2):79-88
   PubMed Web of Science ®Google Scholar